Effect of arsenic trioxide or ATRA on primary APL cell or HL-60 cells and their value analysis in hyperleukocytosis

Chinese Journal of Cancer Research

Volumn 13, Issue 2, 2001, Pages 119-123

  Jiang, Guo Sheng ^b   Tang, Tian Hua ^a   Sun, Guan Lin ^b   Zhang, Yu Kun ^a   Wu, Wei Li ^b   Zhao, Liang Yu ^a   Ren, Hai Quan ^a   Dong, Qiang ^a   Ren, Qing Hua ^a   Jiang, Feng Qin ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

APL; Asenic trioxide; Hyperleukocytosis

Indexed keywords

ARSENIC TRIOXIDE; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; CROSS RESISTANCE; DRUG EFFECT; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKOCYTOSIS; PROMYELOCYTE;

EID: 0034944846     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-001-0028-6     Document Type: Article

References (13)

1. Variation of serum G-CSF level in APL treated with all-trans retinoic acid[J]
2. Study on relationship between G-CSF and hyperleukocytosis induced by ATRA in patients with APL[J]
3. Relationship between G-CSF and hyperleukocytosis in patients with APL after treatment with all-trans retinoic acid[J]
4. Study on mechanism of hyperleukocytosis induced by ATRA in patients with APL[J]
5. Application for retinoids in cancer therapy[J]
6. Preliminary study on arsenic trioxide-induced NB4 cells apoptosis and its molecular mechanisms[J]
7. Treatment of acute promyelocytic leukemia with intravenous arsenic trioxide[J]
8. Early deaths and antihemorrhagic treatments in acute promylocytic leukemia[J]
9. Use of all tans retinoic acid in the treatment of acute promyelocytic leukemia[J]
10. Use of arsenic trioxide in the treatment of acute promyelocytic leukemia (APL): I.AS203 exerts dose-dependent dual effects on APL cells[J]
11. Detection of interleukin 6 level in patients with acute promyelocytic leukemia[J]
12. Studies on relation between TNF and acute promyelocytic leukemia[J]
13. Study on variation its value of serum sICAM-1 and sIVAM-1 in patients with APL[J]